APTUS PHARMA PLANS ₹51 CRORE FUND RAISE FOR EXPANSION

• 🚀 Board approved raising up to ₹51 crore for business expansion • 📈 Fundraising to include preferential allotment of securities worth ₹35 crore • 🏦 Additional debt funding/borrowings of ₹10 crore planned • 💰 Company will contribute ₹6 crore through internal accruals • 👨‍💼 Managing Director authorized to identify and negotiate with potential investors for the preferential issue • 📋 Final terms, issue price, investor details and allotment structure to be approved in a subsequent board meeting 🟢 Impact: Positive — Fundraising is aimed at business expansion and could support future growth, capacity enhancement and operational scaling.

APTUS VALUE HSG FIN I LTD

← Back to feed